Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 12, 2003

View Archived Issues

Beneficial effects described for NN-2211 in the treatment of type 2 diabetes

Novel 5-HT1 receptor ligands discovered by GSK researchers

AstraZeneca presents dual CCR3 modulators/histamine H1 antagonists

New 5-HT6 receptor ligands designed by Akzo Nobel scientists

Two series of carbamate-based analgesic agents newly developed at Gruenenthal

AxyS presents novel factor VIIa/factor Xa inhibitors

Novel Jak kinase inhibitors for use in inflammation and cancer

ArQule completes Cyclis acquisition

Requip sNDA for restless legs syndrome filed

Aventis and Regeneron enter global agreement for VEGF Trap

Takeda acquires Japanese rights to antiobesity drug candidate ATL-962

Private equity financing to advance development of Panvac-VF and Prostvac-VF

NIAID grant supports development of oral smallpox drug at Chimerix

Phase I trial evaluates Psoraxine for psoriasis

Antisoma acquires Cytogen's R-1549 royalty rights

Clofarabine granted fast track status for pediatric leukemia

Improved glycemic control associated with exenatide in diabetes

SBIR grant supports BioSante's oral insulin development efforts

Rexin-G designated an orphan drug for pancreatic cancer

Phase I/II trial approved to evaluate Collidem in colorectal cancer

StaphVAX immunogenicity trial successfully completed

Positive endoscopy results for NCX-4016

NDA filed for cinacalcet hydrochloride

EntreMed grants Oxford BioMedica gene rights for ophthalmic applications

Abilify sNDA approved for maintaining stability in patients with schizophrenia

Taisho discusses design and SAR of group II mGluR antagonists at ACS meeting

Inhibitors of procollagen C-endopeptidase synthesized and evaluated as potential antifibrotic agents

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...